Important Safety Information | Prescribing Information | Indications and Usage | Medical Information | Report An Adverse Event
Important Safety Information
Prescribing Information | Indications & Usage
Medical Information | Report An Adverse Event
Contact a Recordati Rare Diseases Representative
Support Icon

Contact a Recordati Rare
Diseases Representative
For U.S. Healthcare Professionals For U.S. Patients

Resources for Patients

Patient Liaison (PL) Program


The Patient Liaison* will call enrolled patients to:

1Provide education and answer questions about AIP and PANHEMATIN

2Help patients if issues arise accessing PANHEMATIN

3Connect patients with other resources regarding AIP

Calls are available in English and Spanish. Translation services can be utilized for other languages.

*These services are provided at no additional cost to your patients by Recordati Rare Diseases to help them manage their PANHEMATIN therapy. Information provided by the PL program is for educational purposes only and is not intended to replace the advice of patients’ healthcare providers.

To get started, your patients can complete the program enrollment opt-in form:

COMPLETE THE OPT-IN FORM

Watch this video to learn about the Panhematin PL program:

Learn about the PANHEMATIN PL program and how to enroll

Resources for your patients to help them prepare for AIP attacks

Living with AIP can be challenging, but having a plan in place will allow your patients to focus on getting the care they need when they have an AIP attack.

DOWNLOAD an AIP ATTACK PLAN

template for your patients to fill out with key action steps and contact information

COMPLETE the AIP MEDICAL EMERGENCY LETTER

for your patients to have on hand if they need to seek emergency care

DOWNLOAD TO A MOBILE DEVICE:
AIP Medical Emergency Letter

Instructional video: How to add the AIP Medical Emergency Letter to a mobile device

PANHEMATIN Patient Support Program

Contact the Recordati Rare Diseases Patient Support Program for Assistance

Monday-Friday between 9:00 AM and 5:00 PM ET

Phone: 866-209-7604; Fax: 866-209-7599z


Access and Reimbursement Support

BENEFITS INVESTIGATION

— Determining whether the patient’s insurance will cover PANHEMATIN

PRIOR AUTHORIZATIONS/APPEALS

— Facilitating the prior authorization process by determining requirements, coordinating paperwork, and following up on the final decision

REIMBURSEMENT SUPPORT

— Assisting with inquiries regarding coverage and reimbursement as they relate to PANHEMATIN

INSURANCE COUNSELING

— Helping your patients explore other insurance options if they are uninsured or do not have favorable coverage for PANHEMATIN

Financial Assistance

COPAY ASSISTANCE

— Assisting eligible patients who receive PANHEMATIN infusions in outpatient settings with their insurance copays

PATIENT ASSISTANCE PROGRAM (PAP)

— Assisting qualified uninsured and underinsured patients with gaining access to PANHEMATIN

Advocacy Support

The American Porphyria Foundation educates physicians and the general public, raises funds for research, and advocates for better policy and patient care.

VISIT SITE

The Porphyrias Consortium, part of the Rare Diseases Clinical Research Network founded by the NIH, benefits patients and physicians by enabling a large-scale collaborative effort to develop new strategies and methods for diagnosis, treatment, and prevention of illness and disability resulting from these rare disorders.

VISIT SITE

The National Organization for Rare Diseases (NORD) is a federation of voluntary health organizations dedicated to helping people with rare “orphan” diseases.

VISIT SITE
VISIT SITE
About PANHEMATIN Review Efficacy and Safety Data
Resources for Patients Review Signs and Symptoms

INDICATION(S) AND IMPORTANT SAFETY INFORMATION

What is PANHEMATIN?

PANHEMATIN (hemin for injection) is a prescription medicine used to relieve repeated attacks of acute intermittent porphyria related to the menstrual cycle in affected women, after initial carbohydrate therapy is known or suspected to be inadequate.

Limitations of Use

  • Before starting PANHEMATIN, your doctor may consider an appropriate trial of carbohydrates or sugar per day for 1 to 2 days.
  • Attacks of porphyria may progress to a point where irreversible nerve damage has occurred. PANHEMATIN therapy is intended to prevent an attack from reaching the critical stage of nerve breakdown. PANHEMATIN is not effective in repairing nerve damage that has already occurred.

Indication(s) and Important
Safety Information

+ See More

What is PANHEMATIN?

PANHEMATIN (hemin for injection) is a prescription medicine used to relieve repeated attacks of acute intermittent porphyria related to the menstrual cycle in affected women, after initial carbohydrate therapy is known or suspected to be inadequate.

IMPORTANT SAFETY INFORMATION

Who should not use PANHEMATIN?
Do not take PANHEMATIN if you are allergic to this drug.

Before starting PANHEMATIN, tell your healthcare provider (HCP) about all your medical conditions, including if you are pregnant or plan to become pregnant, breastfeeding or plan to breastfeed. Tell your HCP about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

What are the possible side effects of PANHEMATIN?

PANHEMATIN may cause side effects including:

  • Vein inflammation is possible. Your doctor will use a large arm vein or a central line to administer PANHEMATIN to minimize the possibility of vein inflammation.
  • Elevated iron levels may occur. Your doctor must monitor your iron levels if you receive multiple courses of PANHEMATIN.
  • PANHEMATIN has a short-term and mild blood thinning effect. Avoid blood thinners during PANHEMATIN therapy.
  • Reversible kidney shutdown has occurred when too high a dose of PANHEMATIN was given in a single dose.
  • PANHEMATIN may carry a risk of transmitting agents that can cause infections, such as viruses, and theoretically, the Creutzfeldt-Jakob disease (CJD) agent or other unknown agents.

The most common side effects of PANHEMATIN include headache, fever, infusion site reactions, and vein inflammation.

These are not all the possible side effects of PANHEMATIN. Call your HCP for medical advice about side effects. You are encouraged to report side effects of prescription drugs to the FDA. Call 1-800-FDA-1088 or visit www.fda.gov/medwatch.

When taking PANHEMATIN, do not take drugs such as estrogens (e.g., oral contraceptives), barbiturates (drugs that help with sleep and used to treat epilepsy) or steroids (body hormone-like drugs), because such drugs can trigger an attack or make an attack worse.

PANHEMATIN® (hemin for injection), for intravenous infusion only, is available as powder for reconstitution in 350 mg vials.

Please see the accompanying full Prescribing Information.

 

Important Safety Information

You are about to leave the PANHEMATIN.com website and enter a website operated by an independent third party. The links to third-party websites contained on PANHEMATIN.com are provided solely for your convenience. Recordati Rare Diseases does not control the opinions, claims or comments contained on any third-party website linked to PANHEMATIN.com, and your activities at those websites will be governed by the policies and practices of those third parties.

OK to proceed to third-party website CANCEL to return to PANHEMATIN.com